Löchelt, M., W. Muranyi, and R.M. Flügel, (1993).
Human foamy virus genome posesses an internal, Bel-1-dependent and functional promoter.
Proc. Natl. Acad. Sci. U.S.A. 90: 7317-7321.

Löchelt, M., R.M. Flügel, and M. Aboud. (1994).
The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection.
J. Virol. 68: 638-645.

Löchelt, M., S.F. Yu, M.L. Linial, and R.M. Flügel. (1995).
The human foamy virus internal promoter is required for efficient gene expression and infectivity.
Virology 206: 601-610.

Löchelt, M. and R.M. Flügel. (1995).
Molecular biology of human and primate foamy viruses.
in "The Retroviridae, Vol. 4." (J. Levy, ed.), Plenum Press, New York, pp. 239-292.

Löchelt, M., and Flügel., R.M. (1996).
The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.
J. Virol. 70: 1033-1040.

Bodem, J., M. Löchelt, P. Yang and R. M. Flügel. (1997).
Regulation of gene expression by human foamy virus and potentials of foamy viral vectors.
Hematopoietic Stem Cells 15(suppl. 1): 141-147.

Winkler, I., J. Bodem, L.Haas, M. Zemba, H. Delius, R. P. Flower, R. M. Flügel, and M. Löchelt, (1997).
Characterization of the genome of feline foamy virus and its proteins shows distinct features different from primate spumaviruses.
J. Virol. 71: 6727-6741.

Zemba, M., T. Wilk, T. Rutten, A. Wagner, R. M. Flügel, and M. Löchelt (1998).
The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity.
Virology 247: 7-13.

Zemba, M., A. Alke, J. Bodem, I. G. Winkler, R. L. P. Flower, K.-I. Pfrepper, H. Delius, R. M. Flügel, and M. Löchelt (2000).
Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences.
Virology 266: 150-156.

Wilk, T., F. deHaas, A. Wagner, T. Rutten, S. Fuller, R. M. Flügel, and M. Löchelt (2000). The intact retroviral Env glycoprotein of human foamy virus is a trimer.
J. Virol. 74: 2885-2887.

Wagner, A., A. Schager, M. Aboud, A. Alonso, T. Tokino, R. M. Flügel, and M. Löchelt. (2000). Induction of cellular genes is mediated by the Bel 1 transactivator in foamy virus-infected human cells.
J. Virol. 74: 4441-4447.

Alke, A., A. Schwantes, M. Zemba, R. M. Flügel, and M. Löchelt. (2000). Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus.
Virology 275: 170-176.

Wilk, T., V. Geiselhart, M. Frech, S. D. Fuller, R. M. Flügel, and M. Löchelt (2001). Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain.
J. Virol. 75: 7995-8007.

Alke, A., A. Schwantes, K. Kido, M. Flötenmeyer, R. M. Flügel, and M. Löchelt (2001). The bet Gene of feline foamy virus is required for virus replication.
Virology 287: 310-320.

Kido, K., A. Doerks, M. Löchelt, and R. M. Flügel (2002). Identification and functional characterization of an intragenic DNA binding site for the spumaretroviral trans-activator in the human p57Kip2 gene.
J. Biol. Chem. 277:12032-12039.

Schwantes, A., I. Ortlepp, and M. Löchelt (2002). Construction and functional characterization of feline foamy virus-based retroviral vectors.
Virology 301: 53-63.

Geiselhart, V., A. Schwantes, P. Bastone, M. Frech, and M. Löchelt (2003). Characterization of the feline foamy virus Env leader protein and the N-terminal Gag domain.
Virology 310: 235-244.

Schwantes, A., U. Truyen, J. Weikel, C. Weiss, and Martin Löchelt (2003). Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
J. Virol. 44: 7830-7842.

Weikel, J., M. Löchelt, and U. Truyen (2003). Demonstration of feline foamy virus in experimentally infected cats by immunohistochemistry.
J. Vet. Med. A 50: 415-417.

Löchelt, M. (2003). Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 277: 27-61.
Bastone, P., U. Truyen, and M. Löchelt (2003). Potential of Zoonotic Transmission of Non-Primate Foamy Viruses to Humans.
J. Vet. Med. B 50: 417-423.

Bastone, P. and M. Löchelt. (2004). Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors.
Gene Ther. 11: 465-473.

Geiselhart, V. P. Bastone, T. Kempf, M. Schnölzer, and M. Löchelt. (2004). Furin-Mediated Cleavage of the Feline Foamy Virus Env Leader Protein.
J. Virol. 78:13573-13581.

Romen, F. P. Bastone, Y.-. Kim, R. Wirtz, J. Weikel, U. Truyen und M. Löchelt. (2004). Das zoonotische Potential animaler Foamyviren. Tierärztl. Umschau 59: 521-527.

Lehmann-Che, J., M.-L. Giron, O. Delelis, M. Löchelt, P. Bittoun, J. Tobaly-Tapiero, H. de The, and A. Saib. (2005). Protease-dependent uncoating of a complex retrovirus. J. Virol. 79: 9244-9253.

Löchelt, M., F. Romen, P. Bastone, H. Muckenfuss, N. Kirchner, Y.-B. Kim, U. Truyen, U. Rösler, M. Battenberg, A. Saib, E. Flory, K. Cichutek, and C. Münk. (2005) The anti-retroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U.S.A. 102: 7982-7987.

Romen, F., M. Pawlita, P. Sehr, S. Bachmann, J. Schröder, H. Lutz, and M. Löchelt. (2005). Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats. Virology (in press).

Wirtz, R. and M. Löchelt. (2005). Construction and analysis of genomic, full-length infectious foamy virus DNA clones. In: Methods Mol. Biol. 304: 423-434.

Truyen, U. and M. Löchelt. (2005). Relevant oncogenic viruses in veterinary medicine: Original pathogens and animal models for human disease. In: Contributions to Microbiology, vol 13: Infection and inflammation: Impacts on Oncogenesis. Thomas Dittmar, Axel Schmidt, Kurt S. Zänker (eds), Karger Publishing Company, Basel, Switzerland (in press).

Bastone, P., I. G. Bravo, and M. Löchelt (2005). Feline Foamy Virus-Mediated Marker Gene Transfer: Identification of Essential Genetic Elements and Influence of Truncated and Chimeric Proteins. Virology (in press).